Drug Trial Radar · NCT06202378
Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: Oct 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
270
Actual
Start
Dec 29, 2023
Primary completion
Nov 26, 2024
Study completion Dec 16, 2024
Sponsor
- Lead sponsor
- Shanghai Hutchison Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- Beijing Tiantan Hospital
- First posted
- Jan 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to determine the safety and efficacy of SHPL-49 intravenous infusion for 7 consecutive days in the treatment of acute ischemic stroke subjects.
Conditions
- Acute Ischemic Stroke
Interventions
3 ampoules of SHPL-49 InjectionDrug
3 ampoules of SHPL-49 Injection in 100 mL 0.9% sodium chloride will be administered as a 30-minute intravenous infusion and applied twice daily for 7 days.
6 ampoules of SHPL-49 InjectionDrug
6 ampoules of SHPL-49 Injection in 100 mL 0.9% sodium chloride will be administered as a 30-minute intravenous infusion and applied twice daily for 7 days.
0.9% Sodium Chloride InjectionDrug
100 mL 0.9% sodium chloride will be administered as a 30-minute intravenous infusion and applied twice daily for 7 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Modified Rankin Scale (mRS), with scores of 0-1 at Day 90Time frame: 90±7 days
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tiantan Hosptial,Capital Medical University
Beijing, Beijing Municipality, China
Yuebei People's Hospital
Shaoguan, Guangdong, China
Hengshui People's Hospital
Hengshui, Hebei, China
Tangshan Workers' Hospital
Tangshan, Hebei, China
Nanshi Hospital of Nanyang
Nanyang, Henan, China
General Hospital of Pingmei Shenma Group
Pingdingshan, Henan, China
Keshiketeng Banner Traditional Chinese Medicine and Mongolian Medicine Hospital
Chifeng, Inner Mongolia, China
The First Hospital of Jilin University
Changchun, Jilin, China
Beipiao Central Hospital
Beipiao, Liaoning, China
Shenyang Medical College Affiliated Central Hospital
Shenyang, Liaoning, China
The First People's Hospital of Shenyang
Shenyang, Liaoning, China
Linyi People's Hospital
Linyi, Shandong, China
The First People's Hospital of Tancheng
Linyi, Shandong, China
Sinopharm Tongmei General Hospital
Datong, Shanxi, China
Linfen Central Hospital
Linfen, Shanxi, China
Linfen People's Hospital
Linfen, Shanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.